Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flaxseed oil is an edible plant-derived oil extracted from the seeds of the flax plant (Linum usitatissimum). It is rich in alpha-linolenic acid (ALA), an omega-3 fatty acid. Flaxseed oil is primarily used as a dietary supplement for its potential cardiovascular benefits and to help manage conditions such as high cholesterol and high blood pressure. It has also been studied for its effects on diabetes and inflammation. The mechanism of action involves providing ALA as a precursor to longer-chain omega-3 fatty acids (EPA and DHA), which are involved in anti-inflammatory processes and lipid metabolism[1][5][8]. Flaxseed oil does not have a single pharmaceutical developer; it is produced by various supplement manufacturers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on flaxseed oil.